All‐cause mortality · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality (all‐cause) · patients with chronic obstructive pulmonary disease
It is very uncertain whether remote monitoring changes mortality (all‐cause) compared with usual care (very low certainty).
1 finding from 1 review
Quality of life · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL · patients with chronic obstructive pulmonary disease
2 findings from 1 review
Dyspnea · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
No evidence identified · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to first hospitalisation after starting intervention · patients with chronic obstructive pulmonary disease
It is very uncertain whether remote monitoring plus usual care changes time to first hospitalisation after starting intervention compared with usual care (very low certainty).
1 finding from 1 review
Time to first COPD‐related re‐admission · patients with chronic obstructive pulmonary disease
Remote monitoring plus usual care probably leads to lower time to first COPD‐related re‐admission compared with usual care (moderate certainty).
1 finding from 1 review
Impact on health behaviour: 6MWD · the management of chronic obstructive pulmonary disease
1 finding from 1 review
Number experiencing adverse effects · the management of chronic obstructive pulmonary disease
It is very uncertain whether multi‐component intervention changes adverse events: number of people experiencing an AE compared with other intervention or routine, usual care or control treatment (very low certainty).
1 finding from 1 review
Number of participants experiencing any serious adverse events · the management of chronic obstructive pulmonary disease
Multi‐component intervention showed no clear difference in adverse events: number of people experiencing a serious adverse event compared with other intervention or routine, usual care or control treatment (low certainty).
1 finding from 1 review
Self‐efficacy · the management of chronic obstructive pulmonary disease
2 findings from 1 review
Quality of life: CRQ total, SGRQ total or CAT · the management of chronic obstructive pulmonary disease
1 finding from 1 review
Symptoms of dyspnoea · the management of chronic obstructive pulmonary disease
1 finding from 1 review
Exacerbations · the management of chronic obstructive pulmonary disease
1 finding from 1 review
Impact on health behaviour: 6MWD · the management of chronic obstructive pulmonary disease
1 finding from 1 review
Quality of life St George's Respiratory Questionnaire (SGRQ) score · the management of chronic obstructive pulmonary disease
1 finding from 1 review
Exacerbations (number of people experiencing ≥ 1 exacerbations) · the management of chronic obstructive pulmonary disease
It is very uncertain whether multi‐component intervention changes exacerbations: number of people experiencing at least one exacerbation compared with other intervention or routine, usual care or control treatment (very low certainty).
1 finding from 1 review
Diabetes · Adults with mental disorders in low‐ and middle‐income countries
Atypical showed no clear difference in diabetes (ADA criteria) (6 weeks) compared with typical antipsychotic medications (low certainty).
1 finding from 1 review
Diabetes · Adults with mental disorders in low‐ and middle‐income countries
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found